PRECISION BIOSCIENCES

precision-biosciences-logo

Precision BioSciences is a biotechnology company dedicated to improving lives through its next-generation gene editing technology, ARCUS. Precision BioSciences’ mission is to translate the world’s most powerful genome editing technology into greatly needed products throughout the life sciences. Precision’s proprietary ARCUS genome editing technology enables the production of highly specific nucleases that can insert, remove, and modify DNA at essentially any location in a complex genome.
#SimilarOrganizations #People #Financial #Event #Website #More

PRECISION BIOSCIENCES

Social Links:

facebook

Facebook

linkedin

Linkedin

twitter

Twitter

Industry:
Biotechnology Genetics Health Care Medical

Founded:
2006-01-01

Address:
Durham, North Carolina, United States

Country:
United States

Website Url:
http://www.precisionbiosciences.com

Total Employee:
101+

Status:
Active

Contact:
+1 919 314-5512

Email Addresses:
[email protected]

Total Funding:
265.15 M USD

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Euro Apple Mobile Web Clips Icon Google Font API WordPress Google Maps Font Awesome IPv6


Similar Organizations

translate-bio-logo

Translate Bio

Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.


Current Advisors List

raymond-fschinazi_image

Raymond F.Schinazi Board Member @ Precision BioSciences
Board_member
2019-03-01

robert-adelman_image

Robert Adelman Board Member @ Precision BioSciences
Board_member
2015-05-01

ben-auspitz_image

Ben Auspitz Board Member @ Precision BioSciences
Board_member
2015-04-01

matthew-kane_image

Matthew Kane Board Member @ Precision BioSciences
Board_member

shalini-sharp_image

Shalini Sharp Board Member @ Precision BioSciences
Board_member
2018-12-01

derek-jantz_image

Derek Jantz Board Member @ Precision BioSciences
Board_member

neil-leatherbury_image

Neil Leatherbury Senior Director of Process Sciences @ Precision BioSciences
Board_member
2019-10-01

Current Employees Featured

matthew-kane_image

Matthew Kane
Matthew Kane Co-Founder & Chief Executive Officer @ Precision BioSciences
Co-Founder & Chief Executive Officer
2006-01-01

derek-jantz_image

Derek Jantz
Derek Jantz Co-Founder and Chief Scientific Officer @ Precision BioSciences
Co-Founder and Chief Scientific Officer

jeff-smith_image

Jeff Smith
Jeff Smith Co-Founder, Chief Technical Officer and Chief Science Officer @ Precision BioSciences
Co-Founder, Chief Technical Officer and Chief Science Officer
2007-01-01

michael-amoroso_image

Michael Amoroso
Michael Amoroso President & CEO @ Precision BioSciences
President & CEO
2021-10-01

naresh-tanna_image

Naresh Tanna
Naresh Tanna Vice President of Investor Relations @ Precision BioSciences
Vice President of Investor Relations
2024-02-01

abid-ansari_image

Abid Ansari
Abid Ansari Chief Financial Officer @ Precision BioSciences
Chief Financial Officer
2016-07-01

fayaz-khazi_image

Fayaz Khazi
Fayaz Khazi President @ Precision BioSciences
President
2017-05-01

alex-kelly_image

Alex Kelly
Alex Kelly Chief Corporate Affairs Officer @ Precision BioSciences
Chief Corporate Affairs Officer
2020-10-01

juli-blanche_image

Juli Blanche
Juli Blanche Chief People Officer @ Precision BioSciences
Chief People Officer
2022-05-01

Founder


derek-jantz_image

Derek Jantz

jeff-smith_image

Jeff Smith

matthew-kane_image

Matthew Kane

Stock Details


Company's stock symbol is NASDAQ:DTIL

Investors List

perceptive-advisors_image

Perceptive Advisors

Perceptive Advisors investment in Post-IPO Equity - Precision BioSciences

aquilo-capital-management_image

Aquilo Capital Management

Aquilo Capital Management investment in Post-IPO Equity - Precision BioSciences

lyfe-capital-2_image

LYFE Capital

LYFE Capital investment in Post-IPO Equity - Precision BioSciences

janus-henderson-investors_image

Janus Henderson Investors

Janus Henderson Investors investment in Post-IPO Equity - Precision BioSciences

aliment-capital_image

Aliment Capital

Aliment Capital investment in Debt Financing - Precision BioSciences

f-prime-capital-partners_image

F-Prime Capital

F-Prime Capital investment in Series B - Precision BioSciences

ditch-plains-capital-management_image

Ditch Plains Capital Management LP

Ditch Plains Capital Management LP investment in Series B - Precision BioSciences

cormorant-asset-management_image

Cormorant Asset Management

Cormorant Asset Management investment in Series B - Precision BioSciences

the-longevity-fund_image

The Longevity Fund

The Longevity Fund investment in Series B - Precision BioSciences

leerink-partners_image

Leerink Partners

Leerink Partners investment in Series B - Precision BioSciences

Official Site Inspections

http://www.precisionbiosciences.com Semrush global rank: 3.52 M Semrush visits lastest month: 3.68 K

  • Host name: 30.250.154.104.bc.googleusercontent.com
  • IP address: 104.154.250.30
  • Location: United States
  • Latitude: 38.6583
  • Longitude: -77.2481
  • Timezone: America/New_York

Loading ...

More informations about "Precision BioSciences"

Precision BioSciences - Wikipedia

See details»

Precision BioSciences - Crunchbase Company Profile & Funding

Precision BioSciences is a biotechnology company dedicated to improving lives through its next-generation gene editing technology, ARCUS. Precision BioSciences’ mission is to translate the …See details»

Precision BioSciences, Inc. | LinkedIn

Precision BioSciences, Inc. | 21,539 followers on LinkedIn. Dedicated to Improving Life. | Precision BioSciences, Inc. (Nasdaq: DTIL) is a clinical stage gene editing company developing in vivo ...See details»

Overview - Precision BioSciences

Apr 1, 2025 Precision BioSciences, Inc. (Nasdaq: DTIL), is a clinical stage biotechnology company dedicated to improving life (DTIL) with its novel and proprietary ARCUS® genome …See details»

Precision Biosciences Inc Company Profile - Overview

Website precisionbiosciences.com Telephone 1 919 3145512. No of Employees 108. Industry Pharmaceuticals and Healthcare. Ticker Symbol & Exchange DTIL (NASD) Revenue (2023) …See details»

Precision BioScience - Overview, News & Similar companies

Precision BioScience contact info: Phone number: (919) 314-5512 Website: precisionbiosciences.com What does Precision BioScience do? Precision BioSciences is a …See details»

Precision BioSciences, Inc. - Drug pipelines, Patents, Clinical trials ...

Mar 6, 2025 Explore Precision BioSciences, Inc. with its drug pipeline, therapeutic area, technology platform, 5 clinical trials, 169 news, and 12 literature, Disease Domain:Nervous …See details»

Who We Are - Precision BioSciences

Before Thanksgiving break in 2004, as postdoctoral fellows at Duke University, Jeff Smith, Ph.D. and Derek Jantz, Ph.D. were excited about a new discovery – one that would lead to the …See details»

Precision BioSciences Accelerates Development of PBGENE-DMD …

1 day ago DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop …See details»

Precision BioSciences Announces Clearance of Investigational New …

Mar 17, 2025 Using ARCUS, the Company’s pipeline is comprised of in vivo gene editing candidates designed to deliver lasting cures for the broadest range of genetic and infectious …See details»

Precision BioSciences Corporate Presentation

In our other filings with the SEC, which are accessible on the SEC’s website at www.sec.gov and the Investors page of our website under SEC Filings at investor.precisionbiosciences.com. …See details»

Precision BioSciences Strengthens Senior Leadership Team to …

Jan 29, 2025 - Cindy Atwell, promoted to Chief Development and Business Officer-- Cassie Gorsuch, PhD, promoted to Chief Scientific Officer – DURHAM, N.C.--(BUSINESS WIRE)- …See details»

Our Team - Precision BioSciences

"This website uses cookies for functionality, analytics, personalized content, and ads. By clicking the “Accept All Cookies” or "Accept Non-Essential Cookies" button, you consent to our use of …See details»

Precision BioSciences Accelerates Development of PBGENE-DMD …

1 day ago CureDuchenne is a nonprofit organization recognized as the global leader in research, patient care and innovation for improving and extending the lives of those with …See details»

Precision BioSciences to Report First Quarter 2025 Results on May …

May 8, 2025 Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene edi...See details»

Precision BioSciences Reports First Quarter 2025 Financial Results …

17 hours ago - Announced new clinical data for two programs utilizing ARCUS validating safety and efficacy for Precision’s in vivo gene editing approach - Announced initial data from first …See details»

Precision BioSciences Accelerates Development of PBGENE-DMD …

1 day ago - Precision to host a webcast and conference call on Thursday, May 15, 2025 at 8:00 AM ET - DURHAM, N.C., May 14, 2025--(BUSINESS WIRE)--Precision BioSciences, Inc. …See details»

Precision BioSciences Reports First Quarter 2025 Financial Results …

17 hours ago DURHAM, N.C., May 15, 2025--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop …See details»

Careers - Precision BioSciences

Think you have what it takes to become a Precisioneer? Individuals with disabilities: if you are a qualified individual with a disability and are unable or limited in your ability to use or access the …See details»

Precision BioSciences Announces Presentation of Initial Safety …

May 7, 2025 Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene edi...See details»

linkstock.net © 2022. All rights reserved